Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters (Q35968259)

11 August 2017

Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters (English)

1 reference

11 August 2017

0 references

1 reference

6

France Mentré

1 reference

11 August 2017

Emmanuelle Comets

1

1 reference

11 August 2017

Céline Verstuyft

2

1 reference

11 August 2017

Marc Lavielle

3

1 reference

11 August 2017

Patrice Jaillon

4

1 reference

11 August 2017

Laurent Becquemont

5

1 reference

11 August 2017

13 March 2007

1 reference

11 August 2017

13

1 reference

European Journal of Clinical Pharmacology

inferred from page(s)

published in

1 reference

11 August 2017

63

1 reference

11 August 2017

437-449

1 reference

11 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-007-0269-5

11 August 2017

0 references

cites work

Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Cancer Pharmacogenomics: SNPs, Chips, and the Individual Patient

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Pharmacogenetics: the therapeutic drug monitoring of the future?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

[A new, rapid and robust genotyping method for CYP2C9 and MDR1]

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Evaluation of tests based on individual versus population modeling to compare dissolution curves

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Effect of grapefruit juice on digoxin pharmacokinetics in humans.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Automated covariate model building within NONMEM.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Mixed-Effects Models in Sand S-PLUS

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-007-0269-5

Digoxin pharmacokinetics and MDR1 genetic polymorphisms

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963422

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

14 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17404720

12 December 2020

inferred from PubMed ID database lookup

Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17404720

12 December 2020

inferred from PubMed ID database lookup

Assessment of type I error rates for the statistical sub-model in NONMEM

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17404720

12 December 2020

inferred from PubMed ID database lookup

An improved Bonferroni procedure for multiple tests of significance

1 reference

19 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/BIOMET/73.3.751

Identifiers

DOI

10.1007/S00228-007-0269-5

1 reference

11 August 2017

1 reference

11 August 2017

1 reference